Physician profile
Amber D Jones
NPI 1104207570
$734.65
in general payments reported to CMS, 2019-2025
10 companies · $403 in 2025
The $403 reported for 2025 was more than what 96% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.08 · 2023: $251 · 2024: $53.62 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $259.89 | 2023-2024 | Hemosphere |
| Sumitomo Pharma America, INC. | $121.83 | 2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $91.13 | 2025 | Caplyta |
| Davol INC. | $81.69 | 2025 | Arista |
| Merck Sharp & Dohme LLC | $69.60 | 2021-2025 | Bridion |
| Vertex Pharmaceuticals Incorporated | $25.76 | 2025 | |
| Chiesi USA, INC. | $25.27 | 2024 | Cleviprex |
| Becton, Dickinson and Company | $24.40 | 2025 | Swan-Ganz |
| Pacira Pharmaceuticals Incorporated | $19.38 | 2025 | Exparel |
| Mindray Ds USA, INC. | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.